(Q78138662)
Statements
Protection by a cyclic AMP-specific phosphodiesterase inhibitor, rolipram, and dibutyryl cyclic AMP against Propionibacterium acnes and lipopolysaccharide-induced mouse hepatitis (English)
Propionibacterium acnes
1 reference
Taguchi I
Oka K
Kitamura K
Sugiura M
Oku A